Cardiol Therapeutics wins US patent protection for heart-disease drug platform
The patent will lock in broad protection for the company’s lead therapy CardiolRx and its novel subcutaneous candidate CRD-38
The patent will lock in broad protection for the company’s lead therapy CardiolRx and its novel subcutaneous candidate CRD-38
Stivarga is the standard third-line treatment for metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma
Developed in partnership with the Johns Hopkins Applied Physics Laboratory (APL), the module is built around a multi-segment RT-PCR method with integrated indexing
The modular platform not only targets solid tumors but could also enhance traditional autologous and in vivo T cell therapies
Moraine will serve as OTSAW’s exclusive distributor in Japan, deploying the Camello+ autonomous mobile robot and TransCar autonomous guided vehicle to support hospital logistics
Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
The new plant will manufacture high-quality Type I borosilicate glass tubing
Datamatics will automate the Medication Administration Record process by integrating its intelligent automation products, TruBot and TruCap+
Subscribe To Our Newsletter & Stay Updated